Literature DB >> 7794627

Predicting the outcome of symptomatic congenital cytomegalovirus infection.

C A Jones1, D Isaacs.   

Abstract

The prognosis of babies with symptomatic congenital cytomegalovirus (CMV) infection is worse than for those with asymptomatic CMV, but is difficult to quantify. Babies affected as a result of primary maternal CMV are at greater risk than after reactivation CMV. Chorioretinitis occurs in 10-15% of symptomatic babies and almost always indicates significant mental impairment. Microcephaly occurs in around 50% at birth, but does not always persist, and does not necessarily imply later neurological handicap. Investigative findings that increase the likelihood of handicap include radiographic or computerized tomography scan finding of intracranial calcification and raised cerebrospinal fluid protein. Late deafness is always unpredictable and all babies with congenital CMV infection should have an audiological follow up. The mortality of symptomatic congenital CMV infection is about 30%.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7794627     DOI: 10.1111/j.1440-1754.1995.tb00749.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  3 in total

1.  Prevalence and Characteristics of Cytomegalovirus Ocular Disease in Children: A Multi-Center Study.

Authors:  Carmel L Mercado; Colin P Froines; Eric D Gaier; Qinyun Wang; Maanasa Indaram; Michael J Wan; Ankoor S Shah; Euna B Koo
Journal:  Clin Ophthalmol       Date:  2022-07-08

Review 2.  Congenital cytomegalovirus infection.

Authors:  Alexander K C Leung; Reginald S Sauve; H Dele Davies
Journal:  J Natl Med Assoc       Date:  2003-03       Impact factor: 1.798

3.  Diagnosis of congenital cytomegalovirus infection in high risk neonates.

Authors:  Ehab Abd Elmoniem Albanna; Randa Saddek Abd El-Latif; Hend Alsayed Sharaf; Maha Kamal Gohar; Basem Mohamed Ibrahim
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-07-10       Impact factor: 2.576

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.